Catalyst Wire Dossier Catalyst Wire Dossier

Gliptus 50 mg Tablet

vildagliptin · EVA Pharma
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Gliptus 50 mg Tablet, covering 2016-06-29 to 2016-06-29. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Study of Vildagliptin From Gliptus 50 mg Tablet (EVA Pharma, Egypt) and Galvus 50 mg Tablet (NOVARTIS PHARMA, GERMANY) [Phase 1]

See pricing